Home LiteratureArticle Details
PMID: 9863807 Published · ppublish English Comment Letter

The UK Prospective Diabetes Study.

Lancet (London, England) ·Vol. 352 ·No. 9144 ·1998-12-12 ·Pages 1932-3; author reply 1934

Evans M

Abstract

暂无摘要

MeSH Terms
Diabetes Mellitus, Type 2/drug therapy,mortality Drug Therapy, Combination Humans Hypoglycemic Agents/administration & dosage,adverse effects Metformin/administration & dosage,adverse effects Prospective Studies Randomized Controlled Trials as Topic Sulfonylurea Compounds/administration & dosage,adverse effects
Chemicals
Hypoglycemic Agents Sulfonylurea Compounds Metformin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Evans M
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/S0140-6736(05)60422-9
Published
1998-12-12
Pages
1932-3; author reply 1934
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
PMID: 9742976
CommentOn
PMID: 9742977
External Links
PubMed source DOI: 10.1016/S0140-6736(05)60422-9 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2